Lftd Partners Inc. SEC filings LIFD
Lftd Partners Inc. has 260 filings in SEC EDGAR's recent list, going back to Mar 23, 2007. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (agreement ended, acquisition or sale of assets, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Oct 24, 2024 | Oct 23, 2024 |
| PRE 14A | Preliminary proxy statement | Oct 11, 2024 | Oct 11, 2024 |
| DEF 14C | Information statement | Apr 6, 2021 | Apr 5, 2021 |
| PRE 14C | Acquired sales corp. - pre14c | Mar 23, 2021 | Mar 22, 2021 |
| PRE 14C | Filing | Jan 17, 2020 | Jan 8, 2020 |
| PRE 14C | Filing | Oct 15, 2019 | Oct 1, 2019 |
| DEF 14C | Information statement | Aug 9, 2011 | Aug 2, 2011 |
| PRE 14C | Preliminary information statement 14c 12-9-10 | Dec 10, 2010 | Dec 9, 2010 |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LIFD (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Jacksonville, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1391135
- Former names
- Acquired Sales CORP (until Sep 2, 2021); ACQUIRED SALES CORP (until Sep 2, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.